Global Pharmaceuticals & Biotech Big Green Snowflakes

Nektar Therapeutics

Market Cap: US$923.7m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

ABIVAX Société Anonyme

Market Cap: €5.6b

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

CASI Pharmaceuticals

Market Cap: US$36.3m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

NeOnc Technologies Holdings

Market Cap: US$162.5m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Hemostemix

Market Cap: CA$20.8m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Cell Source

Market Cap: US$22.9m

A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.

Marizyme

Market Cap: US$131.0

A multi-technology life science company, engages in the research, manufacture, and commercialization of medical devices, diagnostics, and products to address clinical needs in the United States, Europe, and Asia.

Hunan Nucien Pharmaceutical

Market Cap: CN¥3.4b

A pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China.

CTCBIO

Market Cap: ₩169.8b

Provides various pharmaceutical products in South Korea and internationally.

Alar Pharmaceuticals

Market Cap: NT$15.5b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

GeneOne Life Science

Market Cap: ₩209.2b

A biopharmaceutical company, engages in the research, development, and contract manufacturing of nucleic acid-based biopharmaceuticals.

Hyundai ADM Bio

Market Cap: ₩130.3b

A contract research organization, provides clinical services in Asia.

Memphasys

Market Cap: AU$11.9m

Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

CORESTEMCHEMON

Market Cap: ₩54.9b

A bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

iX Biopharma

Market Cap: S$17.8m

A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.

Genesystem

Market Cap: ₩33.7b

A biotech engineering company, specializes in molecular testing solutions to target on-site testing needs.

ECS Botanics Holdings

Market Cap: AU$7.8m

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally.

SymBio Pharmaceuticals

Market Cap: JP¥7.0b

Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.

NatureCellLtd

Market Cap: ₩1.5t

Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.

AccuStem Sciences

Market Cap: US$28.1m

A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.

Bespoke Extracts

Market Cap: US$2.7m

Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.

AEON Biopharma

Market Cap: US$8.7m

A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.

MoonLake Immunotherapeutics

Market Cap: US$3.6b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Ocean Biomedical

Market Cap: US$1.5m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

Oncotelic Therapeutics

Market Cap: US$20.5m

A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.

Hamlet BioPharma

Market Cap: €1.1b

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Abpro Holdings

Market Cap: US$13.7m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.

Yubo International Biotech

Market Cap: US$1.5m

Through its subsidiaries, focuses on the research, development, and application of endometrial stem cells.

Tikun Olam-Cannbit Pharmaceuticals

Market Cap: ₪31.2m

Engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.

Guizhou Bailing Group Pharmaceutical

Market Cap: CN¥8.3b

Guizhou Bailing Group Pharmaceutical Co., Ltd.

Genexine

Market Cap: ₩252.9b

Operates as a biotechnology company that focuses on the development and commercialization of immunotherapies in South Korea and internationally.

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States.

HANDOK

Market Cap: ₩153.9b

Operates as a pharmaceutical company.

Althea Group Holdings

Market Cap: AU$18.2m

Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.

BrightPath Biotherapeutics

Market Cap: JP¥6.7b

Engages in the development of cancer immunotherapy drugs in Japan.

Gongwin Biopharm Holdings

Market Cap: NT$12.6b

A clinical-stage biopharmaceutical company, develops anticancer drugs.